On July 13, 2021, AngelMD is hosting the Healthcare Impact Investing Summit with a coalition of partners all focused on improving innovation in healthcare. The event was born out of frustration with what is often billed as "Impact Investing" but instead is fee based social engineering at the expense of American retirees. Instead, impact investing in healthcare has potential for sizable returns while also working to solve real healthcare challenges that will affect all of us and our families at one time or another.
TearSolutions' lead product, called Lacripep, delivers what no other approved or pipeline drug has been able to: rapid healing of the ocular surface and...
Fluo Labs, Inc. is a premarket clinical stage medical device company pursuing innovative technology to provide drug-free relief of nasal allergy (i.e. hay fever)...
MRG address issues involving access to care, chronic disease management, patient adherence & compliance to doctors orders, and frees up clinicians time through leveraging...
